Quick Answer
Clearside Biomedical, Inc. reported Net Income Loss of -$34.35 million for the year ending 2024.
- Clearside Biomedical, Inc. showed a decrease of -5.7% in Net Income Loss from 2023 to 2024.
- This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: -$5.33 million | Q3 2015: -$3.48 million | Q4 2015: -$5.17 million | Q1 2016: -$5.45 million | Q2 2016: -$5.10 million | Q3 2016: -$5.65 million | Q4 2016: -$9.69 million | Q1 2017: -$10.37 million | Q2 2017: -$13.77 million | Q3 2017: -$18.34 million | Q4 2017: -$16.49 million | Q1 2018: -$16.61 million | Q2 2018: -$20.70 million | Q3 2018: -$23.87 million | Q4 2018: -$21.64 million | Q1 2019: -$15.40 million | Q2 2019: -$5.73 million | Q3 2019: -$6.54 million | Q4 2019: -$3.10 million | Q1 2020: -$2.91 million | Q2 2020: -$5.75 million | Q3 2020: -$2.43 million | Q1 2021: -$7.35 million | Q2 2021: -$6.10 million | Q3 2021: -$4.89 million | Q1 2022: -$7.64 million | Q2 2022: -$7.81 million | Q3 2022: -$7.83 million | Q1 2023: -$9.28 million | Q2 2023: -$9.11 million | Q3 2023: -$9.27 million | Q1 2024: -$11.76 million | Q2 2024: -$7.60 million | Q3 2024: -$7.69 million | Q1 2025: -$8.22 million | Q2 2025: -$4.50 million | Q3 2025: -$5.97 million.
- Over the full 11 years of available data (2014 to 2024), Clearside Biomedical, Inc.'s Net Income Loss has declined by 237.1%.
- Historical annual values: Fiscal year 2024: -$34.35 million | Fiscal year 2023: -$32.49 million | Fiscal year 2022: -$32.95 million | Fiscal year 2021: $376.0 thousand | Fiscal year 2020: -$18.21 million | Fiscal year 2019: -$30.77 million | Fiscal year 2018: -$82.82 million | Fiscal year 2017: -$58.98 million | Fiscal year 2016: -$25.88 million | Fiscal year 2015: -$17.64 million | Fiscal year 2014: -$10.19 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: